Jazz Pharmaceuticals Executive and Leadership Team

August, 2026

Leadership Overview

Jazz Pharmaceuticals has 7 executives leading key functions including strategy, human resources, commercial planning, financial operations, medical research, and talent management.

Committed to advancing life-changing therapies, Jazz Pharmaceuticals prioritizes innovation in neuroscience and oncology to improve patient outcomes across global markets.

Leadership Roles at Jazz Pharmaceuticals

  • Chairperson and Chief Executive Officer - Bruce Cozadd
  • Director, Chief of Staff To the Chief Financial Officer - Taryn Stinson
  • Executive Vice President & Chief Financial Officer - Philip Johnson
  • HR Chief of Staff - Kimberly Chaney
  • Commercial Strategy & Planning Chief of Staff - Jessica Ungerleider
  • Chief Medical Officer - Arthur Louie
  • Executive Vice President & Chief People Officer - Heidi Manna
  • Bruce Cozadd - Chairperson and Chief Executive Officer

    Bruce Cozadd, the Chairperson and Chief Executive Officer at Jazz Pharmaceuticals, directs the overarching corporate strategy and long-term vision for the biopharmaceutical organization. Overseeing the integration of neuroscience and oncology research, the Chairperson and Chief Executive Officer ensures alignment between clinical development and commercial objectives. This leadership role involves managing board relations and driving expansion across international markets to solidify the company's position in sleep medicine and hematologic oncology. By fostering a culture of scientific rigor, Bruce Cozadd directly impacts the delivery of specialized therapies to patients worldwide. Through consistent engagement with stakeholders, the Chairperson and Chief Executive Officer maintains the financial health and operational integrity of the enterprise. Ultimately, Cozadd guides the organization toward sustainable growth while addressing complex medical needs in the global healthcare landscape.
    Bruce Cozadd

    Taryn Stinson - Director, Chief of Staff To the Chief Financial Officer

    Taryn Stinson, the Director, Chief of Staff To the Chief Financial Officer at Jazz Pharmaceuticals, manages the financial administrative functions and coordinates strategic reporting for the finance department. Overseeing the flow of critical financial data, the Director, Chief of Staff To the Chief Financial Officer ensures that fiscal planning remains synchronized with the company's research and development investments. This leadership role involves facilitating communication between the finance team and other executive functions to maintain budgetary discipline across global operations. By streamlining financial oversight, Taryn Stinson directly impacts the company's ability to fund innovation in sleep medicine and oncology. Through the management of complex financial projects, the Director, Chief of Staff To the Chief Financial Officer supports the long-term stability of the organization. Ultimately, Stinson provides the structural support necessary for the Chief Financial Officer to execute the company's fiscal strategy.

    Philip Johnson - Executive Vice President & Chief Financial Officer

    Philip Johnson, the Executive Vice President & Chief Financial Officer at Jazz Pharmaceuticals, directs the global financial strategy, capital allocation, and investor relations for the biopharmaceutical firm. Overseeing the fiscal health of the organization, the Executive Vice President & Chief Financial Officer ensures that resources are effectively deployed to support the development of neuroscience and oncology therapies. This leadership role involves managing the balance sheet and driving financial performance to sustain long-term growth in competitive markets. By optimizing the capital structure, Philip Johnson directly impacts the company's capacity to invest in clinical trials and commercial expansion. Through the oversight of financial reporting and risk management, the Executive Vice President & Chief Financial Officer maintains transparency and accountability across the enterprise. Ultimately, Johnson secures the financial foundation required to advance the company's mission of delivering life-changing medicines to patients.

    Kimberly Chaney - HR Chief of Staff

    Kimberly Chaney, the HR Chief of Staff at Jazz Pharmaceuticals, manages internal organizational workflows and coordinates human capital initiatives across the global workforce. Overseeing the execution of talent management strategies, the HR Chief of Staff ensures that internal processes support the company's mission in neuroscience and oncology. This leadership role involves streamlining communication between executive leadership and the broader human resources department to enhance operational efficiency. By optimizing performance management systems, Kimberly Chaney directly impacts the retention and development of specialized talent necessary for biopharmaceutical innovation. Through the implementation of strategic workforce planning, the HR Chief of Staff facilitates a high-performance culture that aligns with corporate goals. Ultimately, Chaney drives the organizational effectiveness required to support the complex research and development activities inherent in the pharmaceutical industry.

    Jessica Ungerleider - Commercial Strategy & Planning Chief of Staff

    Jessica Ungerleider, the Commercial Strategy & Planning Chief of Staff at Jazz Pharmaceuticals, architects the operational frameworks that support the launch and market penetration of neuroscience and oncology products. Overseeing the alignment of commercial objectives with long-term planning, the Commercial Strategy & Planning Chief of Staff ensures that regional market data informs executive decision-making. This leadership role involves coordinating cross-functional teams to optimize product positioning and resource allocation across diverse therapeutic areas. By refining the strategic roadmap, Jessica Ungerleider directly impacts the company's ability to reach patients with movement disorders and solid tumors. Through rigorous analysis of market trends, the Commercial Strategy & Planning Chief of Staff facilitates the execution of growth initiatives that strengthen the company's competitive advantage. Ultimately, Ungerleider secures the operational focus needed to translate scientific breakthroughs into successful commercial outcomes.

    Arthur Louie - Chief Medical Officer

    Arthur Louie, the Chief Medical Officer at Jazz Pharmaceuticals, leads the clinical development and medical affairs strategy for the company's portfolio of neuroscience and oncology products. Overseeing the design and execution of clinical trials, the Chief Medical Officer ensures that all research meets rigorous safety and efficacy standards. This leadership role involves collaborating with regulatory bodies and medical experts to advance therapies for sleep medicine and hematologic tumors. By guiding the scientific direction of the pipeline, Arthur Louie directly impacts the successful transition of products from research to patient care. Through the management of medical evidence generation, the Chief Medical Officer facilitates the integration of clinical insights into the company's broader therapeutic strategy. Ultimately, Louie drives the medical innovation necessary to address unmet needs in movement disorders and complex cancers, ensuring the company remains at the forefront of biopharmaceutical advancement.

    Heidi Manna - Executive Vice President & Chief People Officer

    Heidi Manna, the Executive Vice President & Chief People Officer at Jazz Pharmaceuticals, directs the global human resources strategy, talent acquisition, and organizational culture initiatives. Overseeing the development of a diverse and skilled workforce, the Executive Vice President & Chief People Officer ensures that the company attracts the talent required to excel in the biopharmaceutical sector. This leadership role involves implementing programs that foster employee engagement and professional growth across all regional operations. By aligning human capital strategies with the company's mission in neuroscience and oncology, Heidi Manna directly impacts the organization's ability to innovate and scale. Through the management of compensation, benefits, and leadership development, the Executive Vice President & Chief People Officer maintains a high-performing environment. Ultimately, Manna builds the organizational capacity needed to support the company's long-term objectives and commitment to patient health.
    Heidi Manna

    Explore Leadership Teams in Manufacturing

    Frequently Asked Questions Regarding Jazz Pharmaceuticals Top Executives and Leadership Team

    Who leads Jazz Pharmaceuticals?
    Jazz Pharmaceuticals is led by Bruce Cozadd (Chairperson and Chief Executive Officer), along with executives such as Taryn Stinson (Director, Chief of Staff To the Chief Financial Officer) and Philip Johnson (Executive Vice President & Chief Financial Officer).
    Who is part of Jazz Pharmaceuticals’s executive team?
    The executive team of Jazz Pharmaceuticals includes leaders such as Bruce Cozadd (Chairperson and Chief Executive Officer), Taryn Stinson (Director, Chief of Staff To the Chief Financial Officer), Philip Johnson (Executive Vice President & Chief Financial Officer) and other senior executives.
    How many executives does Jazz Pharmaceuticals have?
    Jazz Pharmaceuticals has 7 executives leading key business areas.
    What roles are included in Jazz Pharmaceuticals’s leadership team?
    The leadership team of Jazz Pharmaceuticals includes roles such as Chairperson and Chief Executive Officer, Director, Chief of Staff To the Chief Financial Officer, Executive Vice President & Chief Financial Officer, HR Chief of Staff, Commercial Strategy & Planning Chief of Staff.